14 results · 37ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

COMPLETE BRAND MULTI-PURPOSE SOLUTION

FDA 510(k)
FDA Class 2 ·Ophthalmic

Ophthalmic Cannula

FDA UDI
KATENA PRODUCTS, INC.·00841668114247·VECTIS 2-HOLE 4MM 25GA (PK/10)

POSSIS MYOCARDIAL SUTURELESS LEAD

FDA Adverse Event
Injury ·POSSIS MEDICAL, INC.·Product code LWS·November 14, 1998

MAXHEALTH WHEELCHAIR, MODEL HE-8631, HE-8621, HE-8651

FDA 510(k)
FDA Class 1 ·Physical Medicine

INSIGHT 4000 ENDOSCOPE

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

AUTOSOFT XC

FDA Adverse Event
Malfunction ·UNOMEDICAL A/S·Product code FPA·November 29, 2024

OT ULTRALINK METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·March 14, 2013

TOTALCARE BARIATRIC

FDA Adverse Event
Malfunction ·HILL-ROM, INC·Product code FNL·February 22, 2011

LIFEVEST WCD 3000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·February 21, 2008

GMK-SPHERE FEMORAL COMPONENT SPHERE CEMENTED SIZE 4+ R

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code JWH·February 7, 2022

LACTOSORB 14 MM RAPIDFLAP CLAMP

FDA Adverse Event
Malfunction ·BIOMET MICROFIXATION·Product code JEY·July 6, 2016

smiths medical portex Venn Reusable Tracheal Tube Introducer, 15Ch x 60cm, REF 14-504-17 and REF 14-504-17JP

FDA Enforcement
Class II ·Ongoing·Smiths Medical ASD, Inc.·December 4, 2024

Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·March 27, 2013

CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024